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A B S T R A C T  
 
Objective: To examine longitudinal associations of multiple physical symptoms with recurrence of 
depressive and anxiety disorders.  
Methods: 
Follow-up data of 584 participants with remitted depressive or anxiety disorders were used from the 
Netherlands Study of Depressive and Anxiety disorders. Multiple physical symptoms were measured 
at baseline (T1) and two-year follow-up (T2) by the Four-Dimensional Symptom Questionnaire 
(4DSQ) somatization subscale. Recurrence of depressive and anxiety disorders was assessed at two-
year (T2) and four-year (T4) follow-up with the Composite International Diagnostic Interview. Logistic 
Generalized Estimating Equations were used to examine associations of multiple physical symptoms 
with recurrence of depressive and anxiety disorders. Depressive (IDS-SR) and anxiety symptoms 
(BAI), and other relevant covariates were taken into account.  
Results: 
Multiple physical symptoms were significantly associated with recurrence of depression (OR=1.04, 
95%CI=1.00-1.08), anxiety (OR=1.07, 95%CI=1.03-1.12), and depressive or anxiety disorders 
(OR=1.06, 95%CI=1.02-1.10), on average over time. Odds ratios did not change substantially when 
the IDS-SR mood-cognition and BAI subjective scale were included as covariates.  
Conclusion: 
The presence of multiple physical symptoms was positively related to recurrence of depressive and 
anxiety disorders, independent of depressive and anxiety symptoms. Knowledge of risk factors for 
recurrence of depressive and anxiety disorders, such as the presence of multiple physical symptoms, 
could provide possibilities for better targeting interventions to prevent recurrence.  
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I N T R O D U C T I O N  
Depressive and anxiety disorders are a leading cause of disease burden, mainly due to their recurrent 
nature [1-3]. The National Institute of Mental Health Collaborative Depression Study, reported 
recurrence rates of depression of 25-40% after two years and up to 85% after fifteen years [4, 5]. 
Strategies to reduce the burden of depressive and anxiety disorders should not only focus on 
treatment of acute episodes but also on prevention of recurrence [6]. Knowledge of  risk factors for 
recurrence of depressive and anxiety disorders could provide a rationale for such preventive 
interventions or long-term treatment and allow possibilities for better targeting care [7]. 
Hardeveld et al. [8] found two main predictors of recurrence of depressive disorders in their 
systematic review: the number of previous depressive episodes and subclinical residual depressive 
symptoms after recovery from the last episode. However, they concluded that knowledge of 
predictors of recurrence of depressive disorders is still incomplete. They recommended more 
prospective research, particularly in the general population, to gain conclusive knowledge of  
predictors of recurrence of depressive disorders.  
Putative predictors of recurrence of depressive and anxiety disorders can be identified by looking at 
predictors of depressive and anxiety disorders in general. One of the factors related to co-
occurrence, onset and course of depressive and anxiety disorders is the presence of multiple physical 
symptoms [9-14]. Despite these relationships, it is poorly understood how multiple physical 
symptoms impact the recurrence of depressive and anxiety disorders in remitted patients. A small 
study [15] concluded that a sustained high number of (medically unexplained) physical symptoms 
was predictive of subsequent recurrence in remitted, recurrently depressed patients. However, so 
far, little research has been performed on this association. 
This study, therefore, examined the longitudinal association of multiple physical symptoms with 
recurrence of depressive and anxiety disorders in a prospective cohort study. Furthermore, as 
symptoms of depression and anxiety are a main predictor of recurrence of depressive and anxiety 
disorders, we took residual depressive and anxiety symptoms into account and examined whether 
excluding somatic features of residual depressive and anxiety symptoms altered our results.  
M E T H O D S  
Design 
This study used four-year prospective data from the Netherlands Study of Depressive and Anxiety 
Disorders (NESDA)[16]. NESDA is an ongoing cohort study that aims to investigate the etiology, 
course and consequences of depressive and anxiety disorders. At baseline (2004-2007) 2981 
participants aged 18 through 65 years were included, consisting of healthy controls; persons with a 
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prior history of a depressive or anxiety disorder; persons with a high risk because of a family history 
or subthreshold depressive or anxiety symptoms; and persons with a current depressive or anxiety 
disorders. Participants were recruited in three settings: the community (n = 564), primary care (n = 
1610), and mental health services (n = 807). Exclusion criteria were a primary diagnosis of obsessive 
compulsive disorder, bipolar disorder or severe addiction disorder, and not being fluent in Dutch. 
Assessments consisted of a diagnostic psychiatric interview, questionnaires, and a medical 
assessment. For the current analyses, we used the assessments at baseline (T0), two-year follow-up 
(T2), and four-year follow-up (T4). All participants provided written informed consent and the 
research protocol was approved by the ethical review boards of participating universities. The design 
and sampling procedure of NESDA have been described in more detail [16]. 
Study population 
Participants who had a depressive (major depressive disorder or dysthymia) or anxiety (panic 
disorder, social phobia, generalized anxiety disorder or agoraphobia) episode in the past but were in 
remission at T0 for at least six months were selected for our study (n = 628). Current and lifetime 
depressive and anxiety disorders were examined using the DSM-IV based Composite International 
Diagnostic Interview (CIDI, version 2.1) [17]. 
Participants who did not participate in any of the follow-up measurements were excluded from 
analyses (n = 40). Additionally, participants without data on the main determinant (multiple physical 
symptoms) on any of the assessments were excluded (n = 4). This resulted in a study sample of 584 
participants. Non-respondents (n = 44) were more often males (54.5%), compared to the study 
sample (28.9%, p = .02). No significant differences were found for any of the other study sample 
characteristics. 
Measures 
Recurrence of depressive and anxiety disorders 
We defined recurrence of depressive and anxiety disorders as the occurrence of a new depressive or 
anxiety disorder episode between T0 and T2, and between T2 and T4, respectively, according to CIDI 
diagnostic criteria. 
Multiple physical symptoms 
The presence of multiple physical symptoms was assessed at T0 and T2 by the somatization subscale 
of the Four-Dimensional Symptom Questionnaire [18, 19]. Somatization is defined as “the tendency 
to experience and communicate somatic distress and symptoms unaccounted for by pathological 
findings, to attribute them to physical illness, and to seek medical help for them” [20]. The 4DSQ 
somatization subscale operationalizes somatization as a high number and frequency  of physical 
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symptoms and does not establish whether physical symptoms are medically unexplained or whether 
participants sought help for these symptoms. Therefore, in this study we used the 4DSQ somatization 
subscale to assess multiple physical symptoms, regardless of their being presented to a doctor or 
being explained. 
The 16 items of the 4DSQ correspond to symptoms participants may have had in the past week (e.g. 
‘during the past week did you suffer from dizziness; painful muscles; headache?’) and are scored on a 
five-point Likert scale (‘no’, ‘sometimes’, ‘regularly’, ‘often’, and ‘very often or constantly’). Item 
scores were recoded into a 3-point scale (‘no’, ‘sometimes’, and ‘regularly’ to ‘very often or 
constantly’) and summed to obtain a total score (0-32). An overall score of 11 or higher is indicative 
of an elevated level of somatization and risk of impaired functioning [18]. The 4DSQ somatization 
subscale has been validated against various measures (e.g. SCL-90 somatization subscale and GP’s 
diagnoses) in a variety of samples, including psychiatric, occupational, and primary care samples [18, 
21].  
Covariates 
Demographic characteristic 
Age, gender and number of years of education were assessed at T0 by self-report questionnaires.   
Chronic somatic diseases 
Chronic somatic diseases may be related to the reporting of physical symptoms and the occurrence 
of depressive and anxiety disorders. Therefore,  we took the number of chronic somatic diseases into 
account in our analyses. At T0, participants were asked whether they suffered from any of the 
chronic somatic diseases mentioned in the interview and whether they received medication or 
treatment for these diseases. The following diseases were surveyed: lung disease, heart diseases or 
infarction, diabetes, stroke, osteoarthritis, cancer, ulcer, intestinal disorders, liver disease, epilepsy 
and thyroid gland disease. Answers were categorized as ‘no chronic somatic disease’, ‘one chronic 
somatic disease’ or ‘two or more chronic somatic disease’. 
Psychosocial characteristics 
As several studies have indicated that neuroticism, mastery and childhood trauma may be associated 
with the presence of multiple physical symptoms as well as with (recurrence of) depressive and 
anxiety disorders, these variables were taken into account as covariates [7, 8, 22-24]. 
Neuroticism was measured by the Neuroticism domain of the NEO-FFI [25]. This domain consists of 
12 items (e.g. “I am not a worrier”), which are scored on a five-point Likert scale. Item scores were 
summed to obtain a total score, ranging from 12 to 60.  
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Mastery, the extent to which a person perceives himself to be in control of events or ongoing 
situations, was measured by the Pearlin Mastery scale [26]. Participants rated their agreement with 
five statements on a five-point Likert scale. A sum score was calculated (5-25), with a higher score 
indicating more feelings of mastery.  
Childhood trauma was assessed retrospectively at T0 by the Nemesis Childhood Trauma Interview 
[27, 28]. In this interview, questions were asked about the frequency of emotional neglect, 
psychological abuse, physical abuse, and sexual abuse before the age of 16. First, answers were 
recoded into three categories for each question (0 = never; 1 = ‘once’, ‘sometimes’; 2 = ’regularly’, 
‘often’, ‘very often’). Second, the sum of frequency of childhood trauma (0-8) was calculated for each 
participant, after which the total score was categorized into five categories (0 = 0, 1-2 = 1, 3-4 =2, 5-6 
= 3, 7-8 = 4)[27].  
Clinical characteristics 
Subclinical residual depressive symptoms and the number of previous depressive episodes are the 
strongest predictors of recurrence of depressive disorders [7, 8, 24]. Also, the recency of the last 
depressive or anxiety episode may be related to the risk of recurrence as well as the reporting of 
physical symptoms. These clinical characteristics were, therefore, considered as covariates. Number 
of previous depressive episodes and recency of the last depressive or anxiety episode were assessed 
at T0 with the CIDI.  
Subclinical residual depressive and anxiety symptoms at T0 were assessed by the Inventory of 
Depressive Symptomatology-Self Report (IDS-SR30) [29, 30] and the Beck Anxiety Inventory (BAI), 
respectively. The BAI is a validated, 21 item self-report instrument which measures the overall 
severity of anxiety [31, 32]. Many instruments measuring depressive and anxiety symptoms tend to 
include some somatic symptoms such as fatigue and palpitations, as these are part of diagnostic 
criteria for depressive and anxiety disorders. For this reason, we also measured depressive and 
anxiety symptoms by means of the BAI subjective scale [32], which consists of seven items covering 
subjective and cognitive features of anxiety, and the 11-item IDS-SR mood-cognition subscale, which 
covers symptoms of depressed mood and cognitions [33]. In contrast, the BAI somatic subscale only 
covers somatic features of anxiety and the IDS-SR anxiety-arousal subscale covers symptoms of 
anxiety, somatic symptoms and somatic agitation/slowing. 
Statistical analyses 
Descriptive statistics were used to describe the sample characteristics at T0. A missing value analysis 
was done to assess whether missing values were at random. 
Logistic Generalized Estimating Equations (GEE) were used to examine the longitudinal association of 
multiple physical symptoms with recurrence of depressive and anxiety disorder.  GEE takes the 
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dependency of the repeated observations of the same participant into account. A time-lag model 
was used in which the presence of multiple physical symptoms (continuous and dichotomous) was 
assessed at T0 and T2, and recurrence of depressive and anxiety disorders was assessed at T2 and T4 
(see Figure 1). Separate analyses were performed  with recurrence of  depressive disorders, 
recurrence of anxiety disorders, and recurrence of depressive or anxiety disorders as the outcome, 
respectively, and were adjusted for covariates in a stepwise manner. First, we adjusted for socio-
demographic characteristics (age, gender and education level). Thereafter, number of chronic 
somatic disorders, recency of the last depressive or anxiety episode, number of previous depressive 
episodes, subclinical depressive (IDS-SR) or anxiety symptoms (BAI) at T0, neuroticism, mastery and 
childhood abuse were entered in the model as fixed factors. We repeated the analyses replacing the 
BAI and IDS-SR by the BAI subjective scale and IDS-SR mood-cognition subscale because these 
subscales contain no somatic features of depressive and anxiety disorders.  
 Lastly, participants who reported a depressive or anxiety episode during the first period (T0-T2) may 
still have been depressed or anxious in the second period (T2-T4), which could imply a chronic 
depressive or anxiety disorder. Therefore, sensitivity analyses were performed in which we excluded 
the assessments in the second period of participants who reported a depressive or anxiety episode at 
T2 (1 month recency) as well as between T2 and T4 (n = 45). 
Analyses were performed with SPSS (version 22) statistical software. Statistical significance was 
tested two-sided at a level of p < .05.  
R E S U L T S  
Characteristics of the study sample at T0 are given in Table 1. Mean age was 44.2 (12.9) years, 71% of 
the participants was female. At T0, 29% scored  ≥ 11 on the 4DSQ somatization subscale, which is an 
indication of impaired functioning. Median 4DSQ score was 6. At T2, 23% of participants scored 
above the cut-off score of 11. Thirty-eight percent (n = 222) of the study sample reported an elevated 
4DSQ score (≥11) at one or more assessments and 59 of these participants scored ≥11 at all three 
assessments. 
Missing data 
We evaluated whether missing values of the main determinant  and outcome variables were related 
to each other. In our study sample, participants with a missing 4DSQ score at T2 (n = 21; χ2 (1) = 
11.18, p = .001) reported a depressive or anxiety episode more often at T4. Participants with missing 
information on depressive or anxiety disorders at T2 (n = 10; χ2 (1) = 6.20, p = .013) reported a 
depressive or anxiety episode more often at T4. Also, participants without information on depressive 
or anxiety disorders at T4 reported a 2.74 (n = 50; t (578) = -3.29, p = .001) and 2.75 (n = 47; t (558) = 
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-3.34, p = .001) points higher 4DSQ score at T0 and T2, respectively, and reported a depressive or 
anxiety episode more often at T2 (n = 50; χ2 (1) = 4.16, p = .041). Missing data on other variables 
were not related to the main determinant and outcome. 
Longitudinal associations between multiple physical symptoms and recurrence of depressive and 
anxiety disorders 
Between the T0 and T2 assessment, 169 of 574 participants (29.4%) developed a depressive or 
anxiety episode; 121 of 574 (21.1%) a depressive episode and 95 of 574 (17.4%) an anxiety episode. 
Between T2 and T4, 138 of 534 participants (25.8%) reported a depressive or anxiety episode; 93 
(17.4%) a depressive episode and 73 (13.7%) an anxiety episode. If we exclude the 169 participants 
who had had a depressive or anxiety episode in the first period, 61 of 376 participants (16.2%) had a 
new episode between T2 and T4. 
Overall, 33.3% of the participants with a 4DSQ score <11 at T0 reported a depressive or anxiety 
episode between T0 and T4, compared to 58.3% of the participants with an elevated (≥11) 4DSQ 
somatization score.  
GEE analyses (Table 2) showed that multiple physical symptoms were significantly associated with 
recurrence of depressive disorder (OR = 1.04, 95%CI = 1.00 to 1.08), anxiety disorder(OR = 1.07, 
95%CI = 1.03 to 1.12), and depressive or anxiety disorders (OR = 1.06, 95%CI = 1.02 to 1.10), on 
average over time. An odds ratio of 1.06 can be interpreted as follows: every unit increase in 4DSQ 
score results in a 6% higher odds of recurrence of depressive or anxiety disorders, within and 
between subjects. Changing the complete IDS and BAI by the IDS mood and cognition subscale and 
the BAI subjective subscale did not change these results substantially. 
Also, an elevated  4DSQ score (≥11) was associated with a higher risk of recurrence of depressive and 
anxiety disorders (Table 3 Appendix, adjusted for sociodemographics; depression: OR = 2.39, 95%CI = 
1.69 to 3.40; anxiety: OR = 2.24, 95%CI = 1.54 to 3.25; depression or anxiety: OR = 2.30, 95%CI = 1.67 
to 3.17). However, these associations were attenuated after adjusting for covariates such as 
depressive symptoms and neuroticism (depression: OR = 1.36, 95%CI = 0.88 to 2.10; anxiety: OR = 
1.42, 95%CI = 0.90 to 2.24; depression or anxiety: OR = 1.48, 95%CI = 0.98 to 2.25).  
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D I S C U S S I O N  
Main findings 
This prospective study showed that multiple physical symptoms were positively associated with 
recurrence of depressive and anxiety disorders, even when residual depressive and anxiety 
symptoms were taken into account.  
Our findings in light of existing literature 
So far, research on the association between multiple physical symptoms and recurrence of 
depressive or anxiety disorders is limited. A study [15] showed that a sustained high number of 
(medically unexplained) physical symptoms was related to recurrence in remitted, recurrently 
depressed patients.  Associations between multiple physical symptoms and the course of depressive 
disorders have been studied more extensively. A systematic review by Huijbregts et al. [12] found 
consistent evidence for a negative association between the presence of physical symptoms and 
treatment response in currently depressed patients. Also, a primary care study found that patients 
with a chronic course had more severe physical symptoms at baseline compared to remitted patients 
[14], while a study using the NESDA data [13] concluded that somatic clusters of persistent 
cardiopulmonary, gastrointestinal, and general symptoms were related to persistence of depressive 
disorders, when two or more of these clusters were present. 
Overall, our results did not change substantially when we adjusted for residual depressive and 
anxiety symptoms and used the IDS mood-cognition and BAI subjective scale, compared to the 
complete IDS and BAI which also cover somatic features of depressive and anxiety disorders. In 
addition, associations between multiple physical symptoms and recurrence of depressive and anxiety 
disorders remained statistically significant after adjusting for covariates such as residual depressive 
or anxiety symptoms. This indicates that multiple physical symptoms and depressive or anxiety 
symptoms are distinctive, but overlapping, concepts, and that multiple physical symptoms are 
related to recurrence of depressive and anxiety disorders regardless of residual depressive or anxiety 
symptoms. Simms et al. [34] studied whether somatic symptoms were statistically independent from 
depressive and anxiety symptoms and concluded that, although a general factor accounted for most 
of symptom variance, specific depressive and somatic symptomatology incrementally predicted 
psychosocial dysfunction and were specific to diagnoses of major depressive disorder and 
somatoform disorder, respectively.   
Finally, when a cut-off score of 11 was used, the presence of multiple physical symptoms was not 
associated with recurrence of depressive and anxiety disorders over four years, after adjusting for 
covariates such as neuroticism.  Explanations for this incongruence could be, for instance, that much 
information is lost when 4DSQ scores are dichotomized, or that neuroticism partly explained the 
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association between multiple psychical symptoms. The odds ratios in our continuous models were 
also attenuated in the adjusted models, which supports the latter explanation. Post-hoc regression 
analyses showed that neuroticism is related to multiple psychical symptoms at T0 (r = 0.39, p < .001; 
β = 0.29 [0.24 to 0.35], p < .001) and to depressive or anxiety disorders during four year follow-up 
(OR = 1.12 [1.09 to 1.15], p < .001) , which is consistent with other studies [35-38]. These results 
suggest that the association between multiple psychical symptoms and depressive and anxiety 
disorders is confounded by neuroticism. 
Strengths and limitations 
One main strength of our study is that we used a prospective cohort, in which multiple physical 
symptoms, depressive and anxiety disorders were measured repeatedly over four years. Besides, 
recurrence of depressive and anxiety disorders was assessed by structured diagnostic interviews, 
covering the complete follow-up period. 
However, our findings should be interpreted in the light of some limitations. First, participants who 
developed a depressive or anxiety episode between T0 and T2 may still have been depressed or 
anxious between T2 and T4. Theoretically, this cannot be seen as remission followed by recurrence 
but as one (chronic) depressive or anxiety episode. Sensitivity analyses, in which we excluded the 
data of the second period (T2-T4) of these participants, showed similar results (Appendix: Table 4).  
Second, multiple physical symptoms were measured with the 4DSQ somatization scale over the past 
week, which is rather short  in relation to a two-year period between assessments. Also, the 4DSQ 
somatization scale does not establish whether physical symptoms are medically unexplained or 
whether participants sought help for these symptoms. Strictly speaking, it does not measure 
somatization but severity of physical symptoms.  
Third, missing values were related to 4DSQ scores and diagnoses of depressive or anxiety disorders. 
For example, participants with a missing 4DSQ score were diagnosed with depressive or anxiety 
disorders more often. This may have resulted in an underestimation of the association between 
multiple physical symptoms and recurrence of depressive and anxiety disorders. However, the 
number of missing values was low, so in our opinion the effect of these selective missing values is 
small. 
Further research and clinical implications 
Although we studied longitudinal associations between multiple physical symptoms and recurrence 
of depressive and anxiety disorders during a four-year period, the number of measurements during 
this time period was limited. More longitudinal research on recurrence of depressive and anxiety 
disorders and its association with multiple physical symptoms is needed, with a higher number of 
repeated measurements. With well-founded knowledge about which risk factors play a role in 
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recurrence of depressive and anxiety disorders, prediction models for recurrence of depressive and 
anxiety disorders can be developed and validated. Such prediction models could establish patients’ 
risk profiles, which allows for better targeted care for recurrent depressive and anxiety disorders 
according to these risk profiles.  
In clinical practice, obtaining patients’ 4DSQ somatization scores could indicate whether a patient is 
at risk of recurrence of depressive or anxiety disorders, and may facilitate the targeting of 
appropriate care [39]. In research, the 4DSQ could be a useful tool to explore the correlations and 
distinctions between somatization, distress, depressive and anxiety disorders.  
Conclusions 
From this prospective study we conclude that multiple physical symptoms were positively associated 
with recurrence of depressive and anxiety disorders over four years, regardless of residual depressive 
and anxiety symptoms. Knowledge of risk factors for recurrence of depressive and anxiety disorders, 
such as the presence of multiple physical symptoms, could provide possibilities for better targeting 
interventions to prevent recurrence. More research is needed to conclude on mechanisms by which 
multiple physical symptoms are related to (recurrence of) depressive and anxiety disorders. 
A C K N O W L E D G E M E N T S  
The infrastructure of the NESDA study (www.nesda.nl) has been funded through the Geestkracht 
program of the Netherlands Organisation for Health Research and Development (Zon-Mw, grant 
number 10-000-1002) and participating universities (VU University Medical Center, Leiden University 
Medical Center, University Medical Center Groningen). 
C O M P E T I N G  I N T E R E S T S  
BT is the copyright owner of the 4DSQ and receives copyright fees from companies that use the 4DSQ 
on a commercial basis (the 4DSQ is freely available for non-commercial use in health care and 
research). BT received fees from various institutions for workshops on the application 
of the 4DSQ in primary care settings. The other authors have no competing interests to report. 
R E F E R E N C E S  
[1] Ormel J, Petukhova M, Chatterji S, Aguilar-Gaxiola S, Alonso J, Angermeyer MC, et al. Disability 
and treatment of specific mental and physical disorders across the world. Br J Psychiatry 
2008;192(5):368-75. 
Multiple Physical Symptoms and Recurrence of Depression and Anxiety 
12 
 
[2] Vos T, Barber RM, Bell B, Bertozzi-Villa A, Biryukov S, Bolliger I, et al. Global, regional, and national 
incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries 
in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. 
Lancet 2015;386(9995):743-800. 
[3] Vos T, Haby MM, Barendregt JJ, Kruijshaar M, Corry J, Andrews G. The burden of major 
depression avoidable by longer-term treatment strategies. Arch Gen Psychiatry 2004;61(11):1097-
103. 
[4] Mueller TI, Leon AC, Keller MB, Solomon DA, Endicott J, Coryell W, et al. Recurrence after 
recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry  
1999;156(7):1000-6. 
[5] Keller MB, Boland RJ. Implications of failing to achieve successful long-term maintenance 
treatment of recurrent unipolar major depression. Biol Psychiatry 1998;44(5):348-60. 
[6] Cuijpers P, Beekman AT, Reynolds CF. Preventing depression: a global priority. JAMA 
2012;307(10):1033-4. 
[7] Burcusa SL, Iacono WG. Risk for recurrence in depression. Clin Psychol Rev 2007;27(8):959-85. 
[8] Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman AT. Prevalence and predictors of 
recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand 
2010;122(3):184-91. 
[9] Dijkstra-Kersten SM, Sitnikova K, van Marwijk HW, Gerrits MM, van der Wouden JC, Penninx BW, 
et al. Somatisation as a risk factor for incident depression and anxiety. J Psychosom Res 
2015;79(6):614-9. 
[10] Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric co‐morbidity 
and management. Int J Methods Psychiatr Res 2003;12(1):34-[43. 
[11] Tylee A, Gandhi P. The importance of somatic symptoms in depression in primary care. Prim 
Care Companion J Clin Psychiatry 2005;7(4):167-76. 
[12] Huijbregts KM, van der Feltz-Cornelis CM, van Marwijk HW, de Jong FJ, van der Windt DA, 
Beekman AT. Negative association of concomitant physical symptoms with the course of major 
depressive disorder: a systematic review. J Psychosom Res 2010;68(6):511-9. 
[13] Bekhuis E, Boschloo L, Rosmalen JGM, de Boer MK, Schoevers RA. The impact of somatic 
symptoms on the course of major depressive disorder. J Affect Disord 2016;205:112-8. 
Multiple Physical Symptoms and Recurrence of Depression and Anxiety 
13 
 
[14] Stegenga BT, Kamphuis MH, King M, Nazareth I, Geerlings MI. The natural course and outcome 
of major depressive disorder in primary care: the PREDICT-NL study. Soc Psychiatry Psychiatr 
Epidemiol 2012;47(1):87-95. 
[15] Lok A, Assies J, Koeter MW, Bockting CL, Wouters LF, Mocking RJ, et al. Sustained medically 
unexplained physical symptoms in euthymic patients with recurrent depression: predictive value for 
recurrence and associations with omega 3- and 6 fatty acids and 5-HTTLPR? J Affect Disord 
2012;136(3):604-11. 
[16] Penninx BW, Beekman AT, Smit JH, Zitman FG, Nolen WA, Spinhoven P, et al. The Netherlands 
Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr 
Res 2008;17(3):121-40. 
[17] Wittchen HU. Reliability and validity studies of the WHO - Composite International Diagnostic 
Interview (CIDI): a critical review. J Psychiatr Res 1994;28(1):57-84. 
[18] Terluin B, van Marwijk HW, Ader HJ, de Vet HC, Penninx BW, Hermens ML, et al. The Four-
Dimensional Symptom Questionnaire (4DSQ): a validation study of a multidimensional self-report 
questionnaire to assess distress, depression, anxiety and somatization. BMC Psychiatry 2006;6:34. 
[19] Terluin B. De Vierdimensionale Klachtenlijst (4DKL): Een vragenlijst voor het meten van distress, 
depressie, angst en somatisatie [The Four-Dimensional Symptom Questionnaire (4DSQ). A 
questionnaire to measure distress, depression, anxiety, and somatization]. Huisarts  Wet 
1996;39(12):538-47. 
[20] Lipowski ZJ. Somatization: the concept and its clinical application. Am J Psychiatry 
1988;145(11):1358-68. 
[21] Terluin B, Rhenen WV, Schaufeli WB, De Haan M. The four-dimensional symptom questionnaire 
(4DSQ): measuring distress and other mental health problems in a working population. Work Stress 
2004;18(3):187-207. 
[22] Bonvanie IJ, van Gils A, Janssens KA, Rosmalen JG. Sexual abuse predicts functional somatic 
symptoms: an adolescent population study. Child Abuse Negl 2015;46:1-7. 
[23] Hardeveld F, Spijker J, De Graaf R, Hendriks SM, Licht CM, Nolen WA, et al. Recurrence of major 
depressive disorder across different treatment settings: results from the NESDA study. J Affect Disord 
2013;147(1-3):225-31. 
[24] Scholten WD, Batelaan NM, van Balkom AJ, Wjh Penninx B, Smit JH, van Oppen P. Recurrence of 
anxiety disorders and its predictors. J Affect Disord 2013;147(1-3):180-5. 
Multiple Physical Symptoms and Recurrence of Depression and Anxiety 
14 
 
[25] Costa PT, McCrae RR. Normal personality assessment in clinical practice: The NEO Personality 
Inventory. Psychol Assess 1992;4(1):5-13. 
[26] Pearlin LI, Schooler C. The structure of coping. J Health Soc Behav 1978:2-21. 
[27] Wiersma JE, Hovens JG, van Oppen P, Giltay EJ, van Schaik DJ, Penninx BW. The importance of 
childhood trauma and childhood life events for chronicity of depression in adults [CME]. J Clin 
Psychiatry 2009;70(7):983-9. 
[28] de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of 
mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey 
and Incidence Study. Am J Psychiatry  2002;159(4):620-9. 
[29] Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C. The inventory for 
depressive symptomatology (IDS): preliminary findings. J Psychiatr Res 1986;18(1):65-87. 
[30] Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive 
Symptomatology (IDS): psychometric properties. Psychol Med 1996;26(3):477-86. 
[31] Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric 
properties. J Consult Clin Psychol 1988;56(6):893. 
[32] Kabacoff RI, Segal DL, Hersen M, Van Hasselt VB. Psychometric properties and diagnostic utility 
of the Beck Anxiety Inventory and the State-Trait Anxiety Inventory with older adult psychiatric 
outpatients. J Anxiety Disord 1997;11(1):33-47. 
[33] Wardenaar KJ, van Veen T, Giltay EJ, den Hollander-Gijsman M, Penninx BW, Zitman FG. The 
structure and dimensionality of the Inventory of Depressive Symptomatology Self Report (IDS-SR) in 
patients with depressive disorders and healthy controls. J Affect Disord 2010;125(1):146-54. 
[34] Simms LJ, Prisciandaro JJ, Krueger RF, Goldberg DP. The structure of depression, anxiety and 
somatic symptoms in primary care. Psychol Med 2012;42(1):15-28. doi: 
10.1017/S0033291711000985. 
[35] Kotov R, Gamez W, Schmidt F, Watson D. Linking ‘big' personality traits to anxiety, depressive, 
and substance use disorders: a meta-analysis. Psychol Bull 2010;136:768-821. 
[36] Klein DN, Kotov R, Bufferd SJ. Personality and depression: explanatory models and review of the 
evidence. Annu Rev Clin Psychol 2011;7:269-295. 
[37] Hyphanti T, Goulia P, Carvalho AF. "Personality traits, defense mechanisms and hostility features 
associated with somatic symptom severity in both health and disease." J Psychosom Res 
2013;75(4):362-369. 
Multiple Physical Symptoms and Recurrence of Depression and Anxiety 
15 
 
[38] Russo J, Katon W, Lin E, Von Korff M, Bush T, Simon G, Walker E. Neuroticism and Extraversion as 
Predictors of Health Outcomes in Depressed Primary Care Patients.  Psychosomatics 1997;38(4):339-
348. http://doi.org/10.1016/S0033-3182(97)71441-5. 
[39] Geraghty AW, Stuart B, Terluin B, Kendrick T, Little P, Moore M. Distinguishing between 
emotional distress and psychiatric disorder in primary care attenders: A cross sectional study of the 
four-dimensional symptom questionnaire (4DSQ). J Affect Disord 2015;184:198-204. 
  
Multiple Physical Symptoms and Recurrence of Depression and Anxiety 
16 
 
 
Figure 1: Time-lag model 
T0: baseline assessment, T2: two-year follow-up assessment, T4 = four-year follow-up assessment,  
MPS: multiple physical symptoms, Dep/Anx: recurrence of depressive or anxiety disorder  
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Table 1: Characteristics of the study sample at T0 (n = 584)  
Characteristics Mean (SD) or frequency (%) 
Age, in years 44.2 (12.9) 
Gender: female 415 (71.1%) 
Education, in years 12.6 (3.19) 
Number of chronic somatic diseases 
0 
1 
2 or more 
344 (58.9%) 
166 (28.4%) 
74 (12.7%) 
Neuroticism (NEO-FFI; 0-48) 20.7 (7.51) 
Mastery (Pearlin mastery scale; 5-25) 18.9 (3.69) 
Frequency of childhood trauma (n = 582) 
0 
1-2 
3-4 
5-6 
7-8 
302 (51.9%) 
135 (23.2%) 
84 (14.4%) 
50 (8.6%) 
11 (1.9%) 
Distress (4DSQ Distress; 0-28) 8.43 (6.59) 
Multiple physical symptoms (4DSQ Somatization; 0-32 7.82 (5.68)   
Multiple physical symptoms (4DSQ Somatization, dichotomized; n=580)  
 < 11 
 ≥ 11 
412 (71%) 
168 (29%) 
Frequent antidepressants use: yes 77 (13.2%) 
Recency of last depressive or anxiety disorder episode 
more than 1 year ago 
less than 1 year ago 
506 (86.6%) 
78 (13.4%) 
Number of previous depressive episodes (n = 523) 
No previous episodes 
1 previous episode 
2 or more previous episodes 
115 (22.0%) 
235 (44.9%) 
173 (33.1%) 
Subclinical depressive symptoms (IDS-SR; 0-84) 14.0 (8.72) 
Subclinical depressive symptoms (IDS-SR mood-cognition; 0-33) 3.99 (3.11) 
Subclinical anxiety symptoms (BAI; 0-63) 7.07 (6.38) 
Subclinical anxiety symptoms (BAI subjective scale; 0-21) 2.58 (2.68) 
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Table 2: Longitudinal associations of multiple physical symptoms (MPS) with recurrence of depressive and 
anxiety disorders (n=584) 
 
Depression Anxiety Depression or anxiety 
OR (95% CI) p OR (95% CI) p OR (95% CI) p 
MPS 
Unadjusted 
 
1.09 (1.06 to 1.12) 
 
<.001 
 
1.10 (1.07 to 1.14) 
 
<.001 
 
1.10 (1.07 to 1.13) 
 
<.001 
MPS 
Adjusted for socio-demographics 
 
1.09 (1.06 to 1.12) 
 
<.001 
 
1.09 (1.06 to 1.13) 
 
<.001 
 
1.09 (1.07 to 1.12) 
 
<.001 
MPS 
Adjusted for all covariates a 
 
1.04 (1.00 to 1.08) 
 
.046 
 
1.07 (1.03 to 1.12) 
 
.001 
 
1.06 (1.02 to 1.10) 
 
.002 
MPS 
BAI / IDS replaced for BAI subjective 
scale / IDS mood-cognition a 
 
1.05 (1.01 to 1.09) 
 
.018 
 
1.07 (1.03 to 1.11) 
 
.001 
 
1.06 (1.02 to 1.09) 
 
.001 
a adjusted for age, gender, education level, number of chronic somatic disorders, recency of the last depressive or anxiety episode, number 
of previous depressive episodes, subclinical depressive or anxiety symptoms at T0, neuroticism, mastery, and childhood abuse. 
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Table 3: Longitudinal associations of multiple physical symptoms (MPS; dichotomous) with recurrence of depressive and 
anxiety disorders (n=584) 
 
Depression Anxiety Depression or anxiety 
OR (95% CI) p OR (95% CI) p OR (95% CI) p 
MPS (>11) 
Unadjusted 
 
2.41 (1.71 to 3.41) 
 
<.001 
 
2.40 (1.66 to 3.47) 
 
<.001 
 
2.39 (1.74 to 3.29) 
 
<.001 
MPS (>11) 
Adjusted for socio-demographics 
 
2.39 (1.69 to 3.40) 
 
<.001 
 
2.24 (1.54 to 3.25) 
 
<.001 
 
2.30 (1.67 to 3.17) 
 
<.001 
MPS (>11) 
Adjusted for all covariates a 
 
1.36 (0.88 to 2.10) 
 
.169 
 
1.42 (0.90 to 2.24) 
 
.130 
 
1.48 (0.98 to 2.25) 
 
.064 
MPS (>11) 
BAI / IDS replaced for BAI subjective 
scale / IDS mood-cognition a 
1.48 (0.96 to 2.29) .077 1.45 (0.93 to 2.29) .105 1.54 (1.04 to 2.28) .032 
a adjusted for age, gender, education level, number of chronic somatic disorders, recency of the last depressive or anxiety episode, number 
of previous depressive episodes, subclinical depressive or anxiety symptoms at T0, neuroticism, mastery and childhood abuse. 
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Table 4: Sensitivity analysis (GEE in which the data of the second period (T2-T4) was excluded for 
participants (n = 45)who reported a depressive or anxiety episode at T2 and during T2 -T4  
 Recurrence of  
depression or anxiety 
OR (95% CI) p 
Multiple physical symptoms 
Unadjusted 
 
1.10 (1.07 to 1.13) 
 
<.001 
Multiple physical symptoms 
Adjusted for socio-demographics 
 
1.10 (1.07 to 1.13) 
 
<.001 
Multiple physical symptoms 
Adjusted for all covariates a 
 
1.06 (1.02 to 1.10) 
 
.005 
Multiple physical symptoms 
BAI /  IDS replaced for BAI subjective scale / IDS mood-cognition a 1.06 (1.02 to 1.09) .002 
a adjusted for age, gender, education level, number of chronic somatic disorders, recency of the last depressive or anxiety episode, number 
of previous depressive episodes, subclinical depressive and anxiety symptoms at T0, neuroticism, mastery and childhood abuse. 
 
